A recent report has shown that a 50% reduction of prothrombin levels in mice heterozygous for a prothrombin-null allele (fII+/− mice) correlated with significantly fewer tumours in a model of inflammation-induced colorectal cancer (CRC)7. This evidence concerns the gene F2 and colorectal cancer.